{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:55:28Z","timestamp":1781816128938,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008455","name":"University of Michigan Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.03.026","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:19:43Z","timestamp":1775315983000},"page":"2593-2599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9223-8493","authenticated-orcid":false,"given":"Jintao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Silaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Eitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.03.026_bib1","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.03.026_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00109-010-0613-6","article-title":"Heme oxygenase-1 gene delivery by sleeping beauty inhibits vascular stasis in a murine model of sickle cell disease","volume":"88","author":"Belcher","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jtha.2026.03.026_bib4","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/ATVBAHA.110.215038","article-title":"Hypoxia and upregulation of hypoxia-inducible factor 1alpha stimulate venous thrombus recanalization","volume":"30","author":"Evans","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.03.026_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.03.026_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism","volume":"33","author":"Kenny","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtha.2026.03.026_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtha.2026.03.026_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.amjmed.2003.07.011","article-title":"Hypercoagulability in sickle cell disease: a curious paradox","volume":"115","author":"Ataga","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2026.03.026_bib9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1182\/blood-2015-05-648030","article-title":"Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices","volume":"126","author":"Da","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib10","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2146\/ajhp090229","article-title":"Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: a review of the literature","volume":"67","author":"Charneski","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jtha.2026.03.026_bib12","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.2019000424","article-title":"Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease","volume":"133","author":"Faes","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-3848(96)00048-5","article-title":"Erythrocyte aggregation and erythrocyte deformability modify the permeability of erythrocyte enriched fibrin network","volume":"82","author":"van Gelder","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.03.026_bib14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.13416","article-title":"Thrombin generation and cell-dependent hypercoagulability in sickle cell disease","volume":"14","author":"Whelihan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.026_bib15","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1074\/jbc.REV120.009309","article-title":"Malaria parasite plasmepsins: more than just plain old degradative pepsins","volume":"295","author":"Nasamu","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.03.026_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.14057","article-title":"mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.03.026_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood-2013-08-523860","article-title":"Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin","volume":"123","author":"Cines","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4899-7678-9_21","article-title":"Hypoxia and its acid-base consequences: from mountains to malignancy","volume":"903","author":"Swenson","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtha.2026.03.026_bib19","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.7150\/thno.99822","article-title":"Microenvironment-responsive nanosystems for ischemic stroke therapy","volume":"14","author":"Wu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jtha.2026.03.026_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/jth.12423","article-title":"The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells","volume":"11","author":"Whelihan","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.026_bib21","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/hae.13692","article-title":"Concurrent homozygous sickle-cell disease and severe haemophilia A: thromboelastography profiles","volume":"25","author":"Zaidi","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.03.026_bib22","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.2021014894","article-title":"HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease","volume":"140","author":"Allali","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.026_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2018.07.002","article-title":"Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients","volume":"72","author":"Santiago","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2026.03.026_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.freeradbiomed.2015.01.012","article-title":"Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration","volume":"82","author":"Irwin","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jtha.2026.03.026_bib25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.14280","article-title":"Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function","volume":"175","author":"Shi","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.03.026_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.03.026_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127860","article-title":"An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease","volume":"4","author":"Redinus","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtha.2026.03.026_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2014.114728","article-title":"Excess of heme induces tissue factor-dependent activation of coagulation in mice","volume":"100","author":"Sparkenbaugh","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.03.026_bib29","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1161\/ATVBAHA.124.322072","article-title":"Spleen tyrosine kinase inhibition mitigates hemin-induced thromboinflammation in an organ-specific manner in sickle cell mice","volume":"45","author":"El-Awaisi","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:15:10Z","timestamp":1781813710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1538783626002163"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.026","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}